Research Article
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients
Table 1
Characterization of NASH and NAFL patients.
| | NAFL () | NASH () | P value |
| | Age (yr) | 44.6 ± 1.3 | 40.7 ± 1.9 | n.s. | | Gender (w) | 56 (79%) | 44 (79%) | n.s. | | BMI (kg/m2) | 53.6 ± 0.9 | 51.2 ± 1.1 | n.s. | | Fasting-glucose (mg/dL) | 106.8 ± 5.2 | 115.3 ± 6.6 | n.s. | | HbA1c (%) | 5.8 ± 0.1 | 6.2 ± 0.2 | n.s. | | Total cholesterol (mg/dL) | 191.3 ± 4.1 | 194.5 ± 5.7 | n.s. | | HDL cholesterol (mg/dL) | 43.3 ± 1.2 | 46.1 ± 2.1 | n.s. | | LDL cholesterol (mg/dL) | 130.7 ± 3.8 | 121.2 ± 5.4 | n.s. | | Triglycerides (mg/dL) | 152.6 ± 21.0 | 157.3 ± 15.2 | n.s. |
|
|
Data are given as mean ± SEM or percentage affected. BMI: Body Mass Index.
|
